92 related articles for article (PubMed ID: 9713961)
1. Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration.
Beck Z; Bácsi A; Kovács E; Kiss J; Kiss A; Balogh E; Telek B; Tóth FD; Andirkó I; Oláh E; Udvardy M; Rak K
Leuk Lymphoma; 1998 Jul; 30(3-4):293-306. PubMed ID: 9713961
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML
Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832
[TBL] [Abstract][Full Text] [Related]
3. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
[TBL] [Abstract][Full Text] [Related]
4. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hermans A; Gow J; Selleri L; von Lindern M; Hagemeijer A; Wiedemann LM; Grosveld G
Leukemia; 1988 Oct; 2(10):628-33. PubMed ID: 3172839
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
6. [Detection of phosphotyrosine in chronic myeloid leukemia cells with PY20 antibody and its clinical applications].
Tian J; Cheng H; Xu KL; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1056-60. PubMed ID: 19698259
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
8. The proto-oncogene expression varies over the course of chronic myeloid leukemia.
Vidović A; Janković G; Colović M; Tomin D; Perunicić M; Bila J; Marković O; Bosković D
Hematology; 2008 Feb; 13(1):34-40. PubMed ID: 18534064
[TBL] [Abstract][Full Text] [Related]
9. Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?
Nieborowska-Skórska M; Nakashima M; Ratajczak M; Steplewski Z; Calabretta B; Skórski T
Folia Histochem Cytobiol; 1994; 32(1):35-40. PubMed ID: 8026602
[TBL] [Abstract][Full Text] [Related]
10. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
MacKenzie E; Stewart E; Birnie GD
Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of c-abl and c-myb oncogenes in Philadelphia chromosome-negative, bcr-negative chronic myeloid leukaemia.
Tóth FD; Kiss J; Kiss A; Telek B; Oláh E; Iványi J; Rak K
Leuk Res; 1994 May; 18(5):373-80. PubMed ID: 8182928
[TBL] [Abstract][Full Text] [Related]
12. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
13. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
[TBL] [Abstract][Full Text] [Related]
14. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
16. [Effects of IFN-alpha combined with IL-6 on cell growth and related genes expression and apoptosis of bone marrow cells from CGL patients].
Chen H; Tang L; Peng X; Luo Z; Luo S; Tan W
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):341-4. PubMed ID: 11877000
[TBL] [Abstract][Full Text] [Related]
17. Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia.
Chandran RK; Geetha N; Sakthivel KM; Aswathy CG; Gopinath P; Raj TVA; Priya G; Nair JKKM; Sreedharan H
Gene; 2019 Feb; 686():85-91. PubMed ID: 30399426
[TBL] [Abstract][Full Text] [Related]
18. Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.
Selleri L; Emilia G; Temperani P; Grassilli E; Zucchini P; Tagliafico E; Bonati A; Venezia L; Ferrari S; Torelli U
Leukemia; 1989 Jul; 3(7):538-42. PubMed ID: 2733455
[TBL] [Abstract][Full Text] [Related]
19. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
[TBL] [Abstract][Full Text] [Related]
20. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
Oshikawa G; Kurosu T; Arai A; Murakami N; Miura O
Cancer Genet Cytogenet; 2010 May; 199(1):56-61. PubMed ID: 20417871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
